Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.

Jørgensen CL, Bjerre C, Ejlertsen B, Bjerre KD, Balslev E, Bartels A, Brünner N, Nielsen DL.

BMC Cancer. 2014 May 22;14:360. doi: 10.1186/1471-2407-14-360.

2.

PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients.

Jørgensen CL, Nielsen TO, Bjerre KD, Liu S, Wallden B, Balslev E, Nielsen DL, Ejlertsen B.

Acta Oncol. 2014 Jun;53(6):776-87. doi: 10.3109/0284186X.2013.865076. Epub 2013 Dec 20.

PMID:
24359601
3.

Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine.

Jørgensen CL, Ejlertsen B, Bjerre KD, Balslev E, Nielsen DL, Nielsen KV.

BMC Cancer. 2013 Nov 12;13:541. doi: 10.1186/1471-2407-13-541.

4.

Breast cancer survival and season of surgery: an ecological open cohort study.

Teilum D, Bjerre KD, Tjønneland AM, Kroman N.

BMJ Open. 2012 Jan 5;2:e000358. doi: 10.1136/bmjopen-2011-000358. Print 2012.

5.

Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group.

Nielsen DL, Bjerre KD, Jakobsen EH, Cold S, Stenbygaard L, Sørensen PG, Kamby C, Møller S, Jørgensen CL, Andersson M.

J Clin Oncol. 2011 Dec 20;29(36):4748-54. doi: 10.1200/JCO.2010.33.9507. Epub 2011 Nov 14.

PMID:
22084374
6.

Classical pathological variables recorded in the Danish Breast Cancer Cooperative Group's register 1978-2006.

Kiaer HW, Laenkholm AV, Nielsen BB, Bjerre KD.

Acta Oncol. 2008;47(4):778-83. doi: 10.1080/02841860802039889.

PMID:
18465348
7.

Improvement of prognosis in breast cancer in Denmark 1977-2006, based on the nationwide reporting to the DBCG Registry.

Mouridsen HT, Bjerre KD, Christiansen P, Jensen MB, Møller S.

Acta Oncol. 2008;47(4):525-36. doi: 10.1080/02841860802027009.

PMID:
18465318
8.

The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise.

Møller S, Jensen MB, Ejlertsen B, Bjerre KD, Larsen M, Hansen HB, Christiansen P, Mouridsen HT; Danish Breast Cancer Cooperative Group.

Acta Oncol. 2008;47(4):506-24. doi: 10.1080/02841860802059259.

PMID:
18465317

Supplemental Content

Loading ...
Support Center